01 Oct Diabetic Eye Care Prime Time Enduring: Addressing Disparities in Diabetic Eye Care
Diabetic Eye Care Prime Time™: Addressing Disparities in Eye Care for Patients With Diabetes
Diabetic retinopathy/diabetic macular edema (DR/DME) continues to affect greater numbers of patients with diabetes, and, unfortunately, in addition to managing the disease, some patient populations experience social determinants that can affect care. Join our multidisciplinary panel of Drs Coney, Kashyap, and Vega for an engaging discussion regarding DR/DME and the importance of understanding the barriers that minority patients with diabetes face. Special focus will be given to starting conversations with patients to identify and address adherence issues, and strategies to help clinicians encourage patients to adhere to and access the best level of care for the management of their diabetes and vision screening.
This activity has been designed to address the educational needs of clinicians involved in the care and management of patients with or at risk for DR/DME including PCPs (ie, internists, FPs, NPs, and PAs), endocrinologists, optometrists, comprehensive ophthalmologists, residents, retina specialists, and retina fellows.
Accredited Providers and Collaborating Partners
This activity is supported by an independent medical educational grant from Regeneron Pharmaceuticals, Inc.
Upon completion of this activity, participants should be able to:
- Identify barriers to diabetic eye care in vulnerable patient populations, such as older patients and racial and ethnic minorities
- Implement strategies that are proven to address disparities in diabetic eye care among underserved patient populations, including racial and ethnic minorities, and older patients
Faculty & Disclosures
Presenting Faculty and Steering Committee
Joseph M. Coney, MD, FASRS, FACS—Chairperson
Retina Associates of Cleveland Inc
Clinical Senior Instructor
Case Western Reserve University
Sangeeta Kashyap, MD
Professor of Medicine
Associate Program Director for Endocrinology, Diabetes and Metabolism Fellowship
Cleveland Clinic Lerner College of Medicine
Associate Editor, Journal of Clinical Endocrinology and Metabolism
Charles Vega, MD, FAAFP
Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Assistant Dean for Culture and Community Education
UC Irvine School of Medicine
UC Irvine Program in Medical Education for the Latino Community
Justine Filippelli, MS, PA-C
Physician Assistant, Oculoplastic and Reconstructive Surgery
Cole Eye Institute
Disclosure of Relevant Financial Relationships
In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Paradigm requires that all planners, faculty, and others who are in a position to control the content of this activity disclose all financial relationships with ineligible companies during the past 24 months.
All relevant relationships are identified and mitigated according to Paradigm policy prior to individuals assuming their roles, and are disclosed prior to learners’ engagement in the activity. Paradigm is committed to providing learners with high-quality accredited continuing education that promotes improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The content of this activity was independently reviewed to ensure that it is fair and balanced, scientifically rigorous, evidence based, and aligned with the public interest. All relevant relationships have been mitigated.
Joseph M Coney, MD, FASRS, FACS—Chairperson
Advisor: AbbVie Inc.; Alimera Sciences; Allergan, Inc.; Apellis Pharmaceuticals, Inc; Genentech, Inc.; Novartis AG; OcuTerra Therapeutics; Regeneron Pharmaceuticals Inc; REGENXBIO, Inc
Consultant: AbbVie, Inc.; Alimera Sciences; Allergan, Inc.; Apellis Pharmaceuticals, Inc; Genentech, Inc.; Novartis AG; Regeneron Pharmaceuticals Inc
Speakers Bureau: AbbVie, Inc.; Alimera Sciences; Allergan, Inc.; Apellis Pharmaceuticals, Inc; Genentech, Inc.; Novartis AG; Regeneron Pharmaceuticals Inc; REGENXBIO, Inc
Grant/Research Funding: AbbVie, Inc.; Alimera Sciences; Allergan, Inc.; Apellis Pharmaceuticals, Inc; Genentech, Inc.; Lowy Medical Research Institute; National Eye Institute; Novartis AG; Regeneron Pharmaceuticals Inc
Justine Filippelli, PA-C
Has no relevant financial relationships with ineligible companies to disclose.
Debbie Hinnen, APN, BC-ADM, CDCES, FAAN, FADCES
Advisor: Boehringer Ingelheim International GmbH; Eli Lilly and Company; Intuity Medical; Novo Nordisk A/S; Sanofi
Consultant: Boehringer Ingelheim International GmbH; Eli Lilly and Company; Novo Nordisk A/S; Sanofi
Speakers Bureau: Boehringer Ingelheim International GmbH; Eli Lilly and Company; Novo Nordisk A/S; Sanofi (Expired 2021)
Sangeeta Kashyap, MD
Advisor: GI Dynamics (Expired)
Consultant: Fractyl Health, Inc (Expired)
Charles Vega, MD
Consultant: GlaxoSmithKline; Johnson & Johnson Services, Inc
Staff planners from American Association of Nurse Practitioners, American Academy of Physician Associates, California Academy of Family Physicians, Center for Sustainable Health Care Quality and Equity, Endocrine Society, Global Education Group, National Minority Quality Forum, Paradigm Medical Communications, LLC, and Salus University Pennsylvania College of Optometry have no relevant financial relationships with ineligible companies to disclose.
Independent peer reviewer has no relevant financial relationships with ineligible companies to disclose.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed Credit
The AAFP has reviewed Eye Connect: Comprehensive Continuum of the Patient’s Journey in Diabetic Eye Care, and deemed it acceptable for AAFP credit. Term of approval is from 08/24/2022 to 08/24/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This session, Diabetic Eye Care Prime Time™ Addressing Disparities in Eye Care for Patients With Diabetes, is approved for 0.50 enduring activity AAFP Prescribed credits.
Optometrist Continuing Education
AAPA Credit Designation Statement
AANP Credit Designation Statement
To receive a certificate of participation, participants must:
- Follow instructions to register or log in with your professional information and complete the preassessment
- View the online activity in its entirety
- Complete and submit the online postassessment and evaluation. You must answer 70% of the postassessment questions correctly to earn credit. You will have unlimited opportunities to successfully complete the postassessment
A certificate of participation will be available for download/printing immediately following your successful completion of the postassessment and evaluation.
For questions regarding CME credit, contact the Paradigm CME Department at email@example.com.
There are no fees for participating in this activity.
This accredited CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.
Supported Browsers (Desktop/Mobile)
Chrome 45+, Firefox 40+, Edge, Edge Chromium, Safari 8+, Opera 31+
This activity may contain PDF documents. Most current browsers support viewing of PDFs natively, but you may also download a free version of Adobe Acrobat Reader here: http://get.adobe.com/reader
Technical Support: If you have any technical problems or playback issues, email us at firstname.lastname@example.org.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.
This CE activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses
If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC must ensure that its activities include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
The materials provided for this activity are for informational purposes only and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
If you have any questions or comments, please email us at email@example.com.
© 2022 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.
Release Date: November 10, 2022
Expiration Date: May 31, 2023
Time to Complete: 30 minutes
Credit: 0.50 hour
Credit Types: AMA PRA Category 1 credit™ / AANP / AAPA / AAFP / COPE
Target Audience: PCPs, endocrinologists, optometrists, comprehensive ophthalmologists, residents, retina specialists, and retina fellows
This initiative is provided by Paradigm Medical Communications, LLC.
In collaboration with the American Association of Nurse Practitioners, American Academy of Physician Associates, California Academy of Family Physicians, Endocrine Society, National Minority Quality Forum, Global Education Group, and Salus University Pennsylvania College of Optometry.
This initiative is supported by an independent medical educational grant from Regeneron Pharmaceuticals, Inc.
Paradigm Medical Communications, LLC presents this resource for educational purposes only. Healthcare professionals are expected to employ their own knowledge and judgement during any discussion with, or treatment of, their patients.